Pyrimidyl sulfonaminde derivative and its use for the treatment of chemokine mediated diseases

Details for Australian Patent Application No. 2009272425 (hide)

Owner AstraZeneca AB

Inventors Stonehouse, Jeffrey Paul; Robbins, Andrew James; Meghani, Premji

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2009272425

PCT Pub. Number WO2010/007427

Priority 61/081,213 16.07.08 US

Filing date 15 July 2009

Wipo publication date 21 January 2010

Acceptance publication date 2 February 2012

International Classifications

C07D 239/48 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

C07D 239/69 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

20 January 2011 PCT application entered the National Phase

  PCT publication WO2010/007427 Priority application(s): WO2010/007427

2 February 2012 Application Accepted

  Published as AU-B-2009272425

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009272430-Assay device and methods

2009272419-Live teleporting system and apparatus